In NAFLD and CKD, fetuin-A, a hepatokine, promotes endothelial dysfunction and vascular wall inflammation of hepatic and glomerular endothelial cells, providing evidence for the role of an inflamed liver28,29. Here, AHSG is linked to metabolic dysfunction-associated steatotic liver disease.